Please ensure Javascript is enabled for purposes of website accessibility

Why Bionano Genomics Stock Surged Today and Then Plunged in After-Hours Trading

By Joe Tenebruso - Jan 19, 2021 at 6:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The genome testing company's investors endured a volatile day.

What happened

Shares of Bionano Genomics (BNGO 4.52%) rose 8.4% during market hours on Tuesday, only to fall roughly 10% after the market closed.

So what

Investors bid up Bionano's stock price after the biotech said on Monday that its Saphyr optical genome mapping (OGM) system could detect structural variants that could make people more likely to get severe forms of COVID-19.

Investors were also likely pleased when the results of a study released on Tuesday showed Saphyr could detect all clinically important variants of cancer genomes in people with myelodysplastic syndromes (MDS), precursors to acute myeloid leukemia (AML). Notably, Saphyr could do so in a single assay -- rather than the multiple tests required by current methods -- and thus potentially help patients receive care faster.

A finger points to a digital stock chart that rises sharply and then falls.

Bionano Genomics' stock reversed course on Tuesday. Image source: Getty Images.

However, Bionano's share price fell approximately 10% in after-hours trading after the company announced a public stock offering. Bionano did not disclose the number of shares it intends to sell.

Now what

Bionano previously completed a stock sale of roughly $100 million on Jan. 12. The company's decision to sell more shares so soon could mean management believes that in recent weeks Bionano's stock price might have risen too far, too fast.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bionano Genomics, Inc. Stock Quote
Bionano Genomics, Inc.
$1.62 (4.52%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.